Article Sidebar

PDF
Date Published: 28/02/2023
Online Published: 03/03/2023
Abstract Views: 228
Views PDF: 178
DOI: https://doi.org/10.55046/vjrnm.50.682.2023
Issue
No. 50 (2023)
Section
Scientific research
How to Cite
Nguyễn, T. P., Mai, H. S., Nguyen, T. N., Le, D. H., Nguyen, T. T. N., & Le, N. H. (2023). The relationship between thyroglobulin, thyroglobulin doubling time and recurrent/metastatic lesions detected in 18F-FDG PET/CT in radioiodine refractory differentiated thyroid cancer. Vietnamese Journal of Radiology and Nuclear Medicine, 50, 61-69. https://doi.org/10.55046/vjrnm.50.682.2023

The relationship between thyroglobulin, thyroglobulin doubling time and recurrent/metastatic lesions detected in 18F-FDG PET/CT in radioiodine refractory differentiated thyroid cancer

Thị Phương Nguyễn1,, Mai Hong Son2, Nguyen Thi Nhung2, Le Duy Hung2, Nguyen Thi Tuyet Nhung3, Le Ngoc Ha2
1 Khoa Y học hạt nhân - Bệnh viện TƯQĐ 108
2 Military Central Hospital 108
3 Hospital 198

Main Article Content

Abstract

The relationship between thyroglobulin, thyroglobulin doubling time and recurrent/metastatic lesions detected in 18F-FDG PET/CT in radioiodine refractory differentiated thyroid cancer


Abstract


Background: 18F-FDG PET/CT is method with high sensitivity and specificity in the diagnosis of recurrent lesions in patients with radioiodine refractory differentiated thyroid cancer ((RAI-R- DTC). The aim of this study was to evaluate the relationship between Tg, Tg – DT and rucurrent/metastatic lessions detected in 18F-FDG PET/CT imaging in RAI-R DTC patients.


Methods: 119 RAI-R DTC patients underwent 18F-FDG PET/CT. At least two consecutive Tg measurements under the thyroid hormone replacement therapy (TSH ≤ 0,1 uIU/ml) to calculate Tg - DT before 18F-FDG PET/CT scan. We analyzed the relationship between PET/CT imaging and clinical characteristics, risk of recurrence, Tg and Tg – DT.


Results: 18F-FDG PET/CT imaging detected recurrent lesions in 88 patients (73,9 %) and distant metastasis in 29 patient (24,3 %). Tg-DT was significantly lower in the positive PET/CT group compared to negative PET/CT group (median 12.9 vs 166 months, p< 0.001). Serum Tg concentration in the patients with distant metastasis was higher than those without distant metastasis (334 ng/ml vs 114.6 ng/ml, p < 0.001). In univariate and multivariate logistic regression analysis, Tg-DT was an independent predictor of positive PET/CT and serum Tg concentration was a predictor of distant metastasis. The ROC curve determines the optimal threshold of Tg - DT in predicting positive PET/CT is 34.75 months and Tg level at 218.1 ng/ml predicting distant metastasis


Conclusion: Tg - DT is reliable value in predicting positive 18F - FDG PET/CT and serum Tg concentration is valuable for predicting the outcome of distant metastasis in  RAI – R DTC patients.


Keywords: thyroglobulin, thyroglobulin doubling time, differentiated thyroid carcinoma, 18F - FDG PET/CT.

Article Details

Keywords

thyroglobulin, thyroglobulin doubling time, differentiated thyroid carcinoma, 18F - FDG PET/CT.

References

1. Haugen B. R. et al. (2016), “2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer”, Thyroid. 26 (1), pp. 1-133.
2. Haddad R. I. et al. (2018), “NCCN guidelines insights: thyroid carcinoma, version 2.2018”. 16 (12), pp. 1429-1440.
3. Worden F. J. T. a. i. m. o. (2014), “Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer”. 6 (6), pp. 267-279.
4. Caetano R. et al. (2016), “Accuracy of positron emission tomography and positron emission tomography‐CT in the detection of differentiated thyroid cancer recurrence with negative 131I whole‐body scan results: A metaanalysis”. 38 (2), pp. 316-327.
5. Ha LN, Son M. H. et al. (2016), “Value of Dedicated Head and Neck (18)F-FDG PET/CT Protocol in Detecting Recurrent and Metastatic Lesions in Post-surgical Differentiated Thyroid Carcinoma Patients with High Serum Thyroglobulin Level and Negative (131)I Whole-body Scan”, Asia Ocean J Nucl Med Biol. 4 (1), pp. 12-18.
6. Giovanella L. et al. (2012), “Relationship between serum thyroglobulin and 18FDG‐PET/CT in 131I‐negative differentiated thyroid carcinomas”. 34 (5), pp. 626-631.
7. Piccardo A. et al. (2019), “PET/CT in thyroid nodule and differentiated thyroid cancer patients. The evidence-based state of the art”. 20 (1), pp. 47-64.
8. Rössing R. M. et al. (2016), “Serum thyroglobulin doubling time in progressive thyroid cancer”. 26 (12), pp. 17121718.
9. Miyauchi A. et al. (2011), “Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy”. 21 (7), pp. 707-716.
10. Albano D. et al. (2021), “The role of Tg kinetics in predicting 2-[18F]-FDG PET/CT results and overall survival in patients affected by differentiated thyroid carcinoma with detectable Tg and negative 131I-scan”. 74 (2), pp. 332339.
11. Albano D. et al. (2021), “Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [18F] FDG PET/CT in non-iodine avid differentiated thyroid carcinoma”. 48 (2), pp. 461-468.
12. Giovanella L. et al. (2022), “The role of thyroglobulin doubling time in differentiated thyroid cancer: a meta-analysis %J Endocrine Connections”. 11 (4), pp. e210648.
13. Shammas A. et al. (2007), “18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer”. 48 (2), pp. 221-226.
14. https://www.kuma-h.or.jp/english/about/doubling-time-progression-calculator/.
15. Giovanella L. et al. (2013), “Thyroglobulin levels and thyroglobulin doubling time independently predict a positive 18F-FDG PET/CT scan in patients with biochemical recurrence of differentiated thyroid carcinoma”. 40 (6), pp. 874-880.
16. Bùi Quang Biểu (2020), Nghiên cứu hình ảnh 18F-FDG PET/CT ở bệnh nhân ung thư tuyến giáp biệt hóa sau phẫu thuật có thyroglobulin huyết thanh cao và xạ hình 131I âm tính, p 84 -111., Luận án tiến sĩ y học, Viện nghiên cứu y dược học lâm sàng 108.